Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 472 of 1,261
  1. US 10421838

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  2. US 10421805

    Anti-hepatitis C antibodies and antigen binding fragments thereof

    United Kingdom Research and Innovation · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  3. US 10421804

    Anti-Zika virus antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  4. US 10421773

    Bone-selective osteogenic oxysterol bisphosphonate analogs

    The Regents of the University of California · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  5. US 10421752

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  6. US 10421715

    Pleuromutilin derivative having 2-amino phenyl mercaptan side chain as well as preparation method and application thereof

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  7. US 10420851

    Stabilized radiolabeled anti-CD45 immunoglobulin compositions

    Actinium Phamaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  8. US 10420834

    Recombinant metapneumovirus F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  9. US 10421722

    Sulfur-containing compounds targeting vesicular acetylcholine transporter

    The Regents of the University of California · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  10. US 10420918

    Compositions and methods for reducing traumatic edema of the central nervous system

    The Regents of the University of California · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  11. US 10422004

    Diagnostic method for distinguishing forms of esophageal eosinophilia

    The Regents of the University of California · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  12. US 10420829

    Chlamydia vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  13. US 10420813

    Competitive inhibitors of invariant chain expression and/or ectopic clip binding

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  14. US 10420812

    Drug combinations and uses in treating a coughing condition

    Infirst Healthcare Limited · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  15. US 10420832

    Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)

    United Biomedical, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  16. US 10420811

    Cultivation of selenium-rich Cyclocarya paliurus plant, extraction and use of active ingredients thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  17. US 10420793

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  18. US 10420773

    Methods of treating developmental disorders and/or seizure disorders with etifoxine

    OVID THERAPEUTICS INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  19. US 10420758

    Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  20. US 10420751

    Methods of treating inflammatory bowel disease with AMD3100 and tacrolimus

    MedRegen, LLC · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  21. US 10420769

    Methods and compositions for inhibition of polymerase

    BioCryst Pharmaceuticals, Inc. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  22. US 10420747

    Cancer treatment method using ailanthone compounds

    EAST CHINA NORMAL UNIVERSITY · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  23. US 10422807

    Indirect homogeneous mobility shift assays for the detection of biologics in patient samples

    PRECISION IBD, INC. · Granted Sep 24, 2019 · Expires Sep 19, 2039

    granted
  24. US 2019282668

    PTH Compounds with Low Peak-To-Trough Ratios

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Sep 19, 2019 · Expires Sep 14, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.